Paxlovid vs placebo reduced COVID-19-related hospitalization and death due to any cause through 28 days, as well as the duration of COVID-19 symptoms.

With a sweep of the pen, President Donald Trump has ended a Biden administration effort to lower the cost of prescription drugs for people on Medicare and Medicaid.

Women with persistent short sleep during the peripartum period had significantly increased odds of developing metabolic syndrome.

Patients diagnosed with more advanced breast cancer are more likely to have cardiovascular disease, a large study suggests.

For people with diabetes, the use of glucagon-like peptide-1 receptor agonists (GLP-1 RAs) is associated with a reduced risk for certain disorders and conditions.

Childhood BMI trends — specifically moderate BMI and high BMI variability — were associated with high cortisol concentrations at 17 years of age.

From 1999 to 2021, methamphetamine-related mortality surged dramatically, with a significant rise in heroin and synthetic opioid coinvolvement.

HealthDay News — The risk for myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS) is increased following COVID-19, according to a study published online Jan. 13 in the Journal of General ...

A global commission presents a nuanced approach to defining clinical obesity as a chronic illness resulting from the effect of excess adiposity on organ and tissue function.

Provepharm Inc. is recalling 1 lot of Phenylephrine HCl Injection, USP 10mg/mL due to presence of particulate matter in the product.

Black and Hispanic patients have increased mortality rates and lower rates of coronary interventions following in-hospital cardiac arrest.

President Donald Trump's administration has placed a freeze on information being released from government health agencies.